4//SEC Filing
BENSOUSSAN TORRES ROBERT 4
Accession 0001753926-26-000169
CIK 0000822663other
Filed
Jan 22, 7:00 PM ET
Accepted
Jan 23, 4:20 PM ET
Size
38.0 KB
Accession
0001753926-26-000169
Research Summary
AI-generated summary of this filing
Interparfums (IPAR) Director Robert Bensoussan Exercises 1,500 Options
What Happened
- Robert Bensoussan, a director of Interparfums Inc. (IPAR), exercised stock option rights on 2026-01-22 to acquire 1,500 shares at an exercise price of $62.18 per share, a transaction valued at $93,270.
- The filing also reports four separate derivative disposals of 375 shares each at $0.00 (each reported as an M-code derivative transaction on the same date). These disposals are listed at $0 in the filing.
Key Details
- Transaction date: 2026-01-22 (Form 4 filed 2026-01-23; filing appears timely).
- Acquired: 1,500 shares via option exercise at $62.18 — total cash paid $93,270.
- Disposed: 4 × 375 shares at $0.00 (derivative entries) reported on same date.
- Shares owned after transaction: not specified in the provided data.
- Transaction code: M = exercise/conversion of derivative. Disposals reported at $0 often reflect shares withheld to satisfy tax withholding or similar mechanics (see Context).
- No indication in the provided data of a 10b5-1 plan or other special plan; no late filing flag noted.
Context
- For option exercises it’s common for some shares to be surrendered or withheld to cover exercise costs or tax withholding; when those withheld/surrendered shares are reported at $0, they typically reflect that mechanic rather than an open‑market sale.
- An exercised option is not the same as an open‑market purchase or sale: it reflects conversion of a derivative right into shares. Purchases (net cash outflow to acquire shares) are often viewed as a more direct bullish signal than routine tax withholding or option exercises.
- This summary is factual only; the filing does not state motivations behind the transactions.
Insider Transaction Report
Form 4
INTERPARFUMS INCIPAR
BENSOUSSAN TORRES ROBERT
Director
Transactions
- Exercise/Conversion
Common Stock
2026-01-22$62.18/sh+1,500$93,270→ 12,500 total - Exercise/Conversion
Option-right to buy
2026-01-22−375→ 0 totalExercise: $62.18From: 2022-02-01Exp: 2026-01-31→ Common Stock (375 underlying) - Exercise/Conversion
Option-right to buy
2026-01-22−375→ 0 totalExercise: $62.18From: 2023-02-01Exp: 2026-01-31→ Common Stock (375 underlying) - Exercise/Conversion
Option-right to buy
2026-01-22−375→ 0 totalExercise: $62.18From: 2024-02-01Exp: 2026-01-31→ Common Stock (375 underlying) - Exercise/Conversion
Option-right to buy
2026-01-22−375→ 0 totalExercise: $62.18From: 2025-02-01Exp: 2026-01-31→ Common Stock (375 underlying)
Holdings
- 11,000
Common Stock
- 300
Option-right to buy
Exercise: $97.84From: 2023-12-31Exp: 2028-12-30→ Common Stock (300 underlying) - 300
Option-right to buy
Exercise: $97.84From: 2024-12-31Exp: 2028-12-30→ Common Stock (300 underlying) - 300
Option-right to buy
Exercise: $97.84From: 2025-12-31Exp: 2028-12-30→ Common Stock (300 underlying) - 300
Option-right to buy
Exercise: $97.84From: 2026-12-31Exp: 2028-12-30→ Common Stock (300 underlying) - 300
Option-right to buy
Exercise: $97.84From: 2027-12-31Exp: 2028-12-30→ Common Stock (300 underlying) - 300
Option-right to buy
Exercise: $147.71From: 2024-12-29Exp: 2029-12-28→ Common Stock (300 underlying) - 300
Option-right to buy
Exercise: $147.71From: 2025-12-29Exp: 2029-12-28→ Common Stock (300 underlying) - 300
Option-right to buy
Exercise: $147.71From: 2026-12-29Exp: 2029-12-28→ Common Stock (300 underlying) - 300
Option-right to buy
Exercise: $147.71From: 2027-12-29Exp: 2029-12-28→ Common Stock (300 underlying) - 300
Option-right to buy
Exercise: $147.71From: 2028-12-29Exp: 2029-12-28→ Common Stock (300 underlying) - 300
Option-right to buy
Exercise: $130.60From: 2025-12-31Exp: 2030-12-30→ Common Stock (300 underlying) - 300
Option-right to buy
Exercise: $130.60From: 2026-12-31Exp: 2030-12-30→ Common Stock (300 underlying) - 300
Option-right to buy
Exercise: $130.60From: 2027-12-31Exp: 2030-12-30→ Common Stock (300 underlying) - 300
Option-right to buy
Exercise: $130.60From: 2028-12-31Exp: 2030-12-30→ Common Stock (300 underlying) - 300
Option-right to buy
Exercise: $130.60From: 2029-12-31Exp: 2030-12-30→ Common Stock (300 underlying) - 300
Option-right to buy
Exercise: $84.64From: 2026-12-31Exp: 2031-12-30→ Common Stock (300 underlying) - 300
Option-right to buy
Exercise: $84.64From: 2027-12-31Exp: 2031-12-30→ Common Stock (300 underlying) - 300
Option-right to buy
Exercise: $84.64From: 2028-12-31Exp: 2031-12-30→ Common Stock (300 underlying) - 300
Option-right to buy
Exercise: $84.64From: 2029-12-31Exp: 2031-12-30→ Common Stock (300 underlying) - 300
Option-right to buy
Exercise: $84.64From: 2030-12-31Exp: 2031-12-30→ Common Stock (300 underlying)
Signature
/s/ Robert Bensoussan-Torres by Joseph A. Caccamo as attorney-in-fact|2026-01-23
Documents
Issuer
INTERPARFUMS INC
CIK 0000822663
Entity typeother
Related Parties
1- filerCIK 0001211775
Filing Metadata
- Form type
- 4
- Filed
- Jan 22, 7:00 PM ET
- Accepted
- Jan 23, 4:20 PM ET
- Size
- 38.0 KB